Evidence map›Paper›PMID 32272658›Full record

ReviewCancers2020

The Interplay of Dysregulated pH and Electrolyte Imbalance in Cancer.

Khalid O Alfarouk, Samrein B M Ahmed, Ahmed Ahmed, Robert L Elliott, Muntaser E Ibrahim, Heyam S Ali, Christian C Wales, Ibrahim Nourwali, Ahmed N Aljarbou, Adil H H Bashir and 6 more

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 6 countries.

Khalid O AlfaroukAlfarouk Biomedical Research LLC, Temple Terrace, FL 33617, USA.
Samrein B M AhmedCollege of Medicine, University of Sharjah, P. O. Box 27272 Sharjah, UAE.
Ahmed AhmedDepartment of Oesphogastric and General Surgery, University Hospitals of Leicester, Leicester LE5 4PW, UK.
Robert L ElliottThe Sallie A. Burdine Breast Foundation, Baton Rouge, LA 70806, USA.
Muntaser E IbrahimInstitute of Endemic Diseases, University of Khartoum, Khartoum 11111, Sudan.
Heyam S AliDepartment Pharmaceutics, Faculty of Pharmacy, University of Khartoum, Khartoum 11111, Sudan.
Christian C WalesAmerican Biosciences Inc., New York, NY 10913, USA.
Ibrahim NourwaliCollege of Dentistry, Taibah University, Al-Madinah Al-Munwarah 42313, Saudi Arabia.
Ahmed N AljarbouCollege of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia.
Adil H H BashirInstitute of Endemic Diseases, University of Khartoum, Khartoum 11111, Sudan.
Sari T S AlhoufieDepartment of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Taibah University, Al-Madinah Al-Munwarah 42353, Saudi Arabia.
Saad Saeed AlqahtaniClinical Pharmacy Department, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.
Rosa A CardoneDepartment of Biosciences, Biotechnologies, and Biopharmaceutics, University of Bari, 90126 Bari, Italy.ORCID 0000-0002-2011-9135
Stefano FaisDepartment of Oncology and Molecular Medicine, National Institute of Health, Viale Regina Elena, 299, 00161 Rome, Italy.
Salvador HarguindeyInstitute for Clinical Biology and Metabolism, Postas 13, 01004 Vitoria, Spain.ORCID 0000-0002-1725-757X
Stephan J ReshkinDepartment of Biosciences, Biotechnologies, and Biopharmaceutics, University of Bari, 90126 Bari, Italy.ORCID 0000-0001-9757-5908
University of Khartoum · SDTaibah University · SAUniversity of Bari Aldo Moro · ITEast Foundation · USIstituto Superiore di Sanità · ITJazan University · SAQassim University · SAUniversity Hospitals of Leicester NHS Trust · GBUniversity of Sharjah · AE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer cells and tissues have an aberrant regulation of hydrogen ion dynamics driven by a combination of poor vascular perfusion, regional hypoxia, and increased the flux of carbons through fermentative glycolysis. This leads to extracellular acidosis and intracellular alkalinization. Dysregulated pH dynamics influence cancer cell biology, from cell transformation and tumorigenesis to proliferation, local growth, invasion, and metastasis. Moreover, this dysregulated intracellular pH (pHi) drives a metabolic shift to increased aerobic glycolysis and reduced mitochondrial oxidative phosphorylation, referred to as the Warburg effect, or Warburg metabolism, which is a selective feature of cancer. This metabolic reprogramming confers a thermodynamic advantage on cancer cells and tissues by protecting them against oxidative stress, enhancing their resistance to hypoxia, and allowing a rapid conversion of nutrients into biomass to enable cell proliferation. Indeed, most cancers have increased glucose uptake and lactic acid production. Furthermore, cancer cells have very dysregulated electrolyte balances, and in the interaction of the pH dynamics with electrolyte, dynamics is less well known. In this review, we highlight the interconnected roles of dysregulated pH dynamics and electrolytes imbalance in cancer initiation, progression, adaptation, and in determining the programming and reprogramming of tumor cell metabolism.

Indexed as

cancerelectrolytesmetabolismpH

Identifiers

PMID32272658
PMCPMC7226178
OpenAlexW3015541643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.